default author photo

Takeshi Uozumi

National Cancer Center Hospital

Research Center for Cancer Prevention and Screenin

Tokyo

Japan

SCHOLARLY PAPERS

2

DOWNLOADS

59

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

A multi-institutional randomized phase III trial of Neoadjuvant Chemoimmunotherapy Followed by Surgery versus Upfront Surgery in Patients with Resectable Clinical Stage II-III Non-small cell Lung Cancer: JCOG2317 (NATCH-ICI)

Number of pages: 21 Posted: 31 Mar 2026
National Cancer Center Hospital, Kindai University, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, Shizuoka Cancer Center, National Cancer Center Hospital, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital - Department of Thoracic Surgery and Kindai University
Downloads 38 (1,277,121)

Abstract:

Loading...

Non-small-cell lung cancer, neoadjuvant therapy, adjuvant therapy, immunotherapy, Clinical trial

2.

Adjuvant Chemotherapy Intensity and Prognosis in Completely Resected High-Grade Neuroendocrine Lung Carcinoma: A Post Hoc Analysis of JCOG1205/1206

Number of pages: 43 Posted: 22 Apr 2026
Kanagawa Cancer Center, Shizuoka Cancer Center - Division of Thoracic Oncology, National Cancer Center Hospital, Kansai Medical University, University of Tokyo - Department of Surgery, Hiroshima University, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, Osaka City General Hospital, Niigata Cancer Center Hospital, affiliation not provided to SSRN, Dokkyo Medical University, National Cancer Center Hospital East - Department of Thoracic Surgery, National Cancer Center Hospital, affiliation not provided to SSRN, Kyushu University - Kyushu University Hospital and National Cancer Center Hospital - Department of Thoracic Surgery
Downloads 21 (1,470,786)

Abstract:

Loading...

high-grade neuroendocrine carcinoma, Small-cell lung cancer, large-cell neuroendocrine carcinoma, cisplatin, irinotecan, etoposide, Relative dose intensity